FDA.reportPublic FDA data

LECANEMAB - Food and Drug Administration

Set ID
1c683916-2853-400a-9064-1148aaa35eae
Type
Indexing - product concept
Effective date
2024-02-15
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023Product nameEisai Inc.2026-07-21
These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023Product nameEisai Inc.2026-06-30
These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023Product nameEisai Inc.2026-01-23
These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023Product nameEisai Inc.2025-12-16
These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab - irmb ) injection, for intravenous use Initial U.S. Approval: 2023Product nameEisai Inc.2025-08-11
These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023Product nameEisai Inc.2025-08-11